4-amino-8-(2-methoxy-5-methylphenyl)-N-propylcinnoline-3-carboxamide

ID: ALA1783281

PubChem CID: 25132069

Max Phase: Preclinical

Molecular Formula: C20H22N4O2

Molecular Weight: 350.42

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCNC(=O)c1nnc2c(-c3cc(C)ccc3OC)cccc2c1N

Standard InChI:  InChI=1S/C20H22N4O2/c1-4-10-22-20(25)19-17(21)14-7-5-6-13(18(14)23-24-19)15-11-12(2)8-9-16(15)26-3/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,25)

Standard InChI Key:  GTGGDPMSPFTXEJ-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 26 28  0  0  0  0  0  0  0  0999 V2000
    9.9527   -5.2166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9516   -6.0440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6664   -6.4569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6646   -4.8039    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3800   -5.2130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3834   -6.0461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.1026   -6.4574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.0957   -4.7912    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0912   -3.9662    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.6649   -7.2819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8270   -5.2063    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.8213   -6.0424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5414   -4.7937    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2559   -5.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.5412   -3.9687    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.9703   -4.7934    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6849   -5.2057    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3993   -4.7930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9486   -7.6878    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.9468   -8.5120    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6610   -8.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3786   -8.5109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.3769   -7.6880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2362   -7.2716    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.2404   -6.4466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.0938   -8.9222    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 11 13  1  0
  3  6  2  0
 13 14  1  0
  1  2  2  0
 13 15  2  0
  5  8  1  0
 14 16  1  0
  6  7  1  0
 16 17  1  0
  7 12  2  0
 17 18  1  0
 11  8  2  0
 10 19  1  0
  5  4  2  0
 19 20  2  0
  8  9  1  0
 20 21  1  0
  4  1  1  0
 21 22  2  0
  3 10  1  0
 22 23  1  0
 23 10  2  0
 11 12  1  0
 19 24  1  0
  5  6  1  0
 24 25  1  0
 22 26  1  0
M  END

Associated Targets(Human)

GABRG2 Tclin GABA-A receptor; alpha-2/beta-3/gamma-2 (949 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA-A receptor; alpha-1/beta-2/gamma-2 (1171 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRG2 Tclin GABA-A receptor; alpha-3/beta-3/gamma-2 (1250 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA2 Tclin GABA receptor alpha-2 subunit (271 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA receptor alpha-1 subunit (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 350.42Molecular Weight (Monoisotopic): 350.1743AlogP: 3.34#Rotatable Bonds: 5
Polar Surface Area: 90.13Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.80CX LogP: 3.31CX LogD: 3.31
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.74Np Likeness Score: -0.90

References

1. Alhambra C, Becker C, Blake T, Chang AH, Damewood JR, Daniels T, Dembofsky BT, Gurley DA, Hall JE, Herzog KJ, Horchler CL, Ohnmacht CJ, Schmiesing RJ, Dudley A, Ribadeneira MD, Knappenberger KS, Maciag C, Stein MM, Chopra M, Liu XF, Christian EP, Arriza JL, Chapdelaine MJ..  (2011)  Development and SAR of functionally selective allosteric modulators of GABAA receptors.,  19  (9): [PMID:21498079] [10.1016/j.bmc.2011.03.035]
2. Mark Wenlock and Nicholas Tomkinson. Experimental in vitro DMPK and physicochemical data on a set of publicly disclosed compounds,  [10.6019/CHEMBL3301361]
3. Maramai S, Benchekroun M, Ward SE, Atack JR..  (2020)  Subtype Selective γ-Aminobutyric Acid Type A Receptor (GABAAR) Modulators Acting at the Benzodiazepine Binding Site: An Update.,  63  (7): [PMID:31738537] [10.1021/acs.jmedchem.9b01312]